Healthcare Trust of America, In (NYSE:HTA):
Healthcare Trust of America, Inc. Sets Dates to Report 2017 Second Quarter and First Half Financial Results and Host Conference Call.
The company is trading up by 0.95 percent from yesterday’s close.
Additionally the company recently declared a dividend paid on Tuesday the 11th of July 2017. The dividend payment was $0.300 per share for the quarter which is $1.20 annualized. This dividend represents a yield of $3.98. The ex-dividend date was set for Thursday the 6th of April 2017.
Healthcare Trust of America, Inc., launched on April 20, 2006, is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations. As of December 31, 2016, the Business’s portfolio consisted of approximately 17.7 million square feet of gross leasable area. As of December 31, 2016, the Business’s portfolio included MOBs, such as single-tenant and multi-tenant, and other healthcare facilities, such as hospitals and senior care. As of December 31, 2016, the Business’s portfolio had 355 buildings located in 31 states..
Shares last traded at $29.79 barely below the 50 day moving average which is $31.54 and which is marginally lower than the 200 day moving average of $30.70. The 50 day moving average went down $-1.69 or -5.36% whereas the 200 day average was down by -2.77%.
The company currently has a P/E ratio of 87.79 and market cap is 4.29B. In the last earnings report the EPS was $0.34 and is estimated to be $0.30 for the current year with 143,841,000 shares outstanding. Next quarter’s EPS is forecasted to be $0.03 and the next full year EPS is anticipated to be $0.15.
Several Wall Street analysts have released ratings on the stock. On June 20 the stock rating was upgraded from “Market Perform” to “Outperform” in a report issued by BMO Capital. On November 7 the company was upgraded to “Outperform” from “” by Raymond James.
On August 25, 2016 BTIG Research started covering the stock with an initial rating of “Buy” and price target of $37.00. SunTrust Robinson Humphrey added HTA to its research portfolio giving it an initial rating of “Buy”.
Equity analyst Oppenheimer began coverage of HTA by announcing an initial rating of “Outperform” and setting a price target of $31.00. On December 9 analysts at Morgan Stanley began coverage of the stock setting a rating of “Equal-weight”.